-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QAPmlxEEeFcu24zG0pcYzk0wQORwajVrj0GGt2S+4YQ6YaduE5qBGbmyXaisllM2 E1frNAgkZytFsjcBr4/x1Q== 0000950144-98-001758.txt : 19980218 0000950144-98-001758.hdr.sgml : 19980218 ACCESSION NUMBER: 0000950144-98-001758 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980217 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NOVEN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000815838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592767632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-40243 FILM NUMBER: 98542483 BUSINESS ADDRESS: STREET 1: 11960 SW 144TH ST CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 MAIL ADDRESS: STREET 1: 11960 SW 144TH STREET CITY: MIAMI STATE: FL ZIP: 33185 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SABLOTSKY STEVEN CENTRAL INDEX KEY: 0001037762 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 11960 SW 144 ST CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 MAIL ADDRESS: STREET 1: 11960 SW 144 ST CITY: MIAMI STATE: FL ZIP: 33186 SC 13G 1 NOVEN PHARMACEUTICALS/STEVEN SABLOTSKY SC 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _____) NOVEN PHARMACEUTICALS, INC. --------------------------- (Name of Issuer) COMMON STOCK ------------------------------ (Title of Class of Securities) 670009-10-9 -------------- (CUSIP Number) Check the following box if a fee is being paid with the statement [ ]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (see Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosure provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 CUSIP NO. 67009-10-9 13G Page 2 of 5 - -------------------------------------------------------------------------------- (1) NAME OF REPORTING PERSON STEVEN SABLOTSKY S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON ###-##-#### - -------------------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (A) [ ] (B) [XX] - -------------------------------------------------------------------------------- (3) SEC USE ONLY - -------------------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION - -------------------------------------------------------------------------------- : (5) SOLE VOTING POWER : (a) 4,694,420 : ----------------------------------------------- : (6) SHARED VOTING POWER NUMBER OF SHARES : BENEFICIALLY : OWNED BY EACH REPORTING ----------------------------------------------- PERSON WITH : (7) SOLE DISPOSITIVE POWER : (a) 4,694,420 ----------------------------------------------- : (8) SHARED DISPOSITIVE POWER : - -------------------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,694,420 - -------------------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES* [XX] - -------------------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 22.9% - -------------------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON IN - -------------------------------------------------------------------------------- 2 3 SCHEDULE 13G ITEM 1: (a) NAME OF ISSUER: Noven Pharmaceuticals, Inc. (b) ADDRESS: 11960 S.W. 144 Street Miami, FL 33186 ITEM 2: (a) NAME OF PERSON FILING: Steven Sablotsky (b) ADDRESS (BUSINESS): 11960 S.W. 144 Street Miami, FL 33186 (c) CITIZENSHIP: U.S.A. (d) TITLE OF CLASS OF SECURITIES: Common Stock (.0001 par value) (e) CUSIP NUMBER: 670009-10-9 ITEM 3: N/A ITEM 4: OWNERSHIP: (a) AMOUNT BENEFICIALLY OWNED: 4,694,420 shares. Of this total, 20,275 shares are indirectly owned by Mr. Sablotsky's spouse; includes 3,352,825 shares which Mr. Sablotsky transferred to Nevon Ventures Limited Partnership, a Nevada limited partnership, on December 30, 1996. Mr. Sablotsky is the beneficial owner of Nevon Ventures Limited Partnership.(1) (b) PERCENT OF CLASS: 22.9% (c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS: (i) sole power to vote or to direct the vote: 4,694,420 (ii) shared power to vote or to direct the vote: N/A (iii) sole power to dispose or to direct the disposition of: 4,694,420 (iv) shared power to dispose or to direct the disposition of: N/A ITEM 5: OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: N/A ITEM 6: OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: N/A - ------------------ (1) Mr. Sablotsky disclaims beneficial ownership of 34,400 shares held in custodial accounts for the benefit of his minor children under the Uniform Transfers to Minors Act and for which neither he nor his wife act as trustees. 3 4 ITEM 7: IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: N/A ITEM 8: IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: N/A ITEM 9: NOTICE OF DISSOLUTION OF GROUP: N/A 4 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement on Schedule 13G is true, complete and correct as of the date hereof. Dated: February 13, 1998 /s/ Steven Sablotsky --------------------------------- STEVEN SABLOTSKY 5 -----END PRIVACY-ENHANCED MESSAGE-----